Humira Market Forecast 2026–2034: Trends & Insights According to a new report from Intel Market Research, the global Humira market was valued at USD 13,120 million in 2024 and is projected to decline from USD 12,080 million in 2025 to USD 6,902 million by 2032, registering a negative CAGR of -9.0% during the forecast period. The market contraction is primarily driven by patent expirations, rapid biosimilar adoption, pricing pressure from payers and pharmacy benefit managers (PBMs), and increasing competition from alternative biologic and targeted therapies. Despite declining branded product revenues, expanding biosimilar availability is improving patient access to adalimumab therapies worldwide. Download Sample Report https://www.intelmarketresearch.com/download-free-sample/16317/humira-market-market